COVID-19 Still a Focus for Infectious Disease Test Developers in 2022, but Ceded Some Ground
Tests for other respiratory viruses, as well as sexually transmitted infections and tuberculosis, moved back into the development pipeline last year.
Stay updated with breaking news from Orasure Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tests for other respiratory viruses, as well as sexually transmitted infections and tuberculosis, moved back into the development pipeline last year.
The companies will share the proceeds of the contract, worth up to $803 million, and provide the tests to HHS.
/PRNewswire/ -- Point of Care Molecular Diagnostics Market Research Report by Product, Technology, Application, End-User, Region - Global Forecast to 2027 -...
How the Market Behaves Before and After Fed Decisions Is Very Different...LABU
Market Study on Infectious Disease In-vitro Diagnostics: Emergence of New Infectious Diseases Opens New Revenue Gate for the Market...